CTVA
Corteva, Inc. · Basic Materials · Agricultural Inputs
$11.92
-5.17% today · -84.82% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- CTVA −5.17% on the last session vs SPY +0.74%: −5.9 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 63 big drops in the past 5 years, CTVA typically lost 0.2% over the next day (median) and was higher only 40% of the time; half the outcomes fell between -0.8% and +0.7%. An ordinary day: +0.1%. Among S&P 500 stocks after big drops, that ranks #494 of 500.
- 0 Reddit mentions in the past 24 hours, 67% positive over the week.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Meta Analyst score · Buy (+0.76)
Every firm's latest rating in the past year, each weighted by its age (a 3-month-old call counts half as much as today's), blended with the consensus of 4 analysts (+1.50, counted like 1.5 fresh ratings). 13 firms, 10 with a call in the past 3 months.
| Firm | Latest rating | Date | Weight |
|---|---|---|---|
| Argus Research | Buy | Sep 18, 2026 | 9% |
| Citigroup | Neutral | Sep 17, 2026 | 9% |
| RBC Capital | Outperform | Sep 16, 2026 | 9% |
| UBS | Neutral | Sep 16, 2026 | 9% |
| BMO Capital | Outperform | Sep 16, 2026 | 9% |
| Keybanc | Sector Weight | Sep 11, 2026 | 8% |
| JP Morgan | Neutral | Aug 3, 2026 | 6% |
| Oppenheimer | Outperform | Jul 23, 2026 | 6% |
| B of A Securities | Buy | Jul 20, 2026 | 6% |
| Mizuho | Outperform | Jul 14, 2026 | 5% |
| Barclays | Overweight | Jun 11, 2026 | 4% |
| Morgan Stanley | Overweight | May 28, 2026 | 4% |
Mean target
$19.50
+63.6% upside
Median target
$19.50
+63.6% upside
Target range
19.00–20.00
low to high
Analysts
4
as of Oct 4
Price vs. targets
Low $19
Mean $20
High $20
Now $11.92
Consensus
Strong buy 2Buy 2Hold 0Sell 0Strong sell 0
Rating and target changes
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| Sep 18, 2026 | Argus Research | Reiterated | Buy | $91.00 |
| Sep 17, 2026 | Citigroup | Raised target | Neutral | $86.00 → $91.00 |
| Sep 16, 2026 | RBC Capital | Reiterated | Outperform | $103.00 |
| Sep 16, 2026 | UBS | Raised target | Neutral | $85.00 → $90.00 |
| Sep 16, 2026 | BMO Capital | Lowered target | Outperform | $100.00 → $95.00 |
| Sep 11, 2026 | Keybanc | Initiated | Sector Weight | — |
| Aug 18, 2026 | UBS | Lowered target | Neutral | $89.00 → $85.00 |
| Aug 3, 2026 | BMO Capital | Raised target | Outperform | $95.00 → $100.00 |
| Aug 3, 2026 | JP Morgan | Raised target | Neutral | $77.00 → $83.00 |
| Aug 3, 2026 | Citigroup | Raised target | Neutral | $85.00 → $86.00 |
| Aug 3, 2026 | UBS | Raised target | Neutral | $86.00 → $89.00 |
| Jul 23, 2026 | Oppenheimer | Raised target | Outperform | $89.00 → $95.00 |
| Jul 21, 2026 | RBC Capital | Raised target | Outperform | $97.00 → $103.00 |
| Jul 20, 2026 | B of A Securities | Raised target | Buy | $90.00 → $96.00 |
| Jul 14, 2026 | Mizuho | Raised target | Outperform | $96.00 → $97.00 |
| Jul 2, 2026 | Mizuho | Raised target | Outperform | $94.00 → $96.00 |
| Jun 11, 2026 | Barclays | Raised target | Overweight | $84.00 → $91.00 |
| Jun 9, 2026 | UBS | Lowered target | Neutral | $90.00 → $86.00 |
| May 28, 2026 | Morgan Stanley | Raised target | Overweight | $84.00 → $95.00 |
| May 7, 2026 | Citigroup | Raised target | Neutral | $83.00 → $85.00 |
| May 7, 2026 | UBS | Raised target | Neutral | $88.00 → $90.00 |
| Apr 24, 2026 | RBC Capital | Raised target | Outperform | $89.00 → $95.00 |
| Apr 22, 2026 | Oppenheimer | Raised target | Outperform | $86.00 → $89.00 |
| Apr 21, 2026 | Wells Fargo | Raised target | Overweight | $85.00 → $90.00 |
| Apr 9, 2026 | UBS | Raised target | Neutral | $80.00 → $88.00 |
| Mar 31, 2026 | Argus Research | Raised target | Buy | $80.00 → $91.00 |
| Feb 17, 2026 | Mizuho | Raised target | Outperform | $80.00 → $82.00 |
| Feb 5, 2026 | JP Morgan | Downgrade | Overweight → Neutral | $75.00 → $77.00 |
| Feb 5, 2026 | Wells Fargo | Raised target | Overweight | $77.00 → $85.00 |
| Feb 5, 2026 | RBC Capital | Raised target | Outperform | $80.00 → $89.00 |
| Feb 5, 2026 | Citigroup | Raised target | Neutral | $74.00 → $80.00 |
| Jan 27, 2026 | Oppenheimer | Raised target | Outperform | $76.00 → $78.00 |
| Jan 21, 2026 | JP Morgan | Raised target | Overweight | $70.00 → $75.00 |
| Jan 21, 2026 | Citigroup | Raised target | Neutral | $70.00 → $74.00 |
| Jan 16, 2026 | Mizuho | Raised target | Outperform | $78.00 → $80.00 |
| Dec 18, 2025 | Citigroup | Raised target | Neutral | $68.00 → $70.00 |
| Nov 11, 2025 | Wells Fargo | Lowered target | Overweight | $80.00 → $77.00 |
| Oct 30, 2025 | UBS | Lowered target | Buy | $85.00 → $81.00 |
| Oct 16, 2025 | Wells Fargo | Lowered target | Overweight | $83.00 → $80.00 |
| Oct 13, 2025 | Argus Research | Lowered target | Buy | $83.00 → $80.00 |
Source: Yahoo Finance analyst data, collected daily.